{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T19:50:32Z","timestamp":1793994632169,"version":"4.8.0"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T00:00:00Z","timestamp":1576022400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T00:00:00Z","timestamp":1576022400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s40620-019-00681-4","type":"journal-article","created":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T09:06:52Z","timestamp":1576055212000},"page":"529-538","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Impact of mineralocorticoid receptor antagonist in renal transplant patients: a systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1093","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9579-8366","authenticated-orcid":false,"given":"Ahmed Mohamed","family":"Abdelhakim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Abd-ElGawad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,12,11]]},"reference":[{"key":"681_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-019-00654-7","author":"ID Kostakis","year":"2019","unstructured":"Kostakis ID, Kassimatis T, Bianchi V et al (2019) UK renal transplant outcomes in low and high BMI recipients: the need for a national policy. J Nephrol. https:\/\/doi.org\/10.1007\/s40620-019-00654-7","journal-title":"J Nephrol"},{"key":"681_CR2","doi-asserted-by":"publisher","first-page":"52","DOI":"10.5500\/wjt.v5.i2.52","volume":"5","author":"M Salvadori","year":"2015","unstructured":"Salvadori M, Rosso G, Bertoni E (2015) Update on ischemia-reperfusion injury in kidney transplantation: pathogenesis and treatment. World J Transplant 5:52\u201367. https:\/\/doi.org\/10.5500\/wjt.v5.i2.52","journal-title":"World J Transplant"},{"key":"681_CR3","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1681\/ASN.2016040477","volume":"28","author":"J Barrera-Chimal","year":"2017","unstructured":"Barrera-Chimal J, Andr\u00e9-Gr\u00e9goire G, Nguyen Dinh Cat A et al (2017) Benefit of mineralocorticoid receptor antagonism in AKI: role of vascular smooth muscle Rac1. J Am Soc Nephrol 28:1216\u20131226. https:\/\/doi.org\/10.1681\/ASN.2016040477","journal-title":"J Am Soc Nephrol"},{"key":"681_CR4","doi-asserted-by":"publisher","first-page":"12270","DOI":"10.1038\/s41598-017-09630-2","volume":"7","author":"I Lima-Posada","year":"2017","unstructured":"Lima-Posada I, Portas-Cort\u00e9s C, P\u00e9rez-Villalva R et al (2017) Gender differences in the acute kidney injury to chronic kidney disease transition. Sci Rep 7:12270. https:\/\/doi.org\/10.1038\/s41598-017-09630-2","journal-title":"Sci Rep"},{"key":"681_CR5","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1096\/fj.09-147926","volume":"24","author":"AND Cat","year":"2010","unstructured":"Cat AND, Griol-Charhbili V, Loufrani L et al (2010) The endothelial mineralocorticoid receptor regulates vasoconstrictor tone and blood pressure. FASEB J 24:2454\u20132463. https:\/\/doi.org\/10.1096\/fj.09-147926","journal-title":"FASEB J"},{"key":"681_CR6","doi-asserted-by":"publisher","first-page":"C788","DOI":"10.1152\/ajpcell.00407.2006","volume":"292","author":"R Gros","year":"2007","unstructured":"Gros R, Ding Q, Armstrong S et al (2007) Rapid effects of aldosterone on clonal human vascular smooth muscle cells. Am J Physiol Cell Physiol 292:C788\u2013C794. https:\/\/doi.org\/10.1152\/ajpcell.00407.2006","journal-title":"Am J Physiol Cell Physiol"},{"key":"681_CR7","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1161\/HYPERTENSIONAHA.110.153619","volume":"57","author":"V Griol-Charhbili","year":"2011","unstructured":"Griol-Charhbili V, Fassot C, Messaoudi S et al (2011) Epidermal growth factor receptor mediates the vascular dysfunction but not the remodeling induced by aldosterone\/salt. Hypertension 57:238\u2013244. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.110.153619","journal-title":"Hypertension"},{"key":"681_CR8","doi-asserted-by":"publisher","first-page":"F78","DOI":"10.1152\/ajprenal.00077.2007","volume":"293","author":"JM Mej\u00eda-Vilet","year":"2007","unstructured":"Mej\u00eda-Vilet JM, Ram\u00edrez V, Cruz C et al (2007) Renal ischemia-reperfusion injury is prevented by the mineralocorticoid receptor blocker spironolactone. Am J Physiol Renal Physiol 293:F78\u2013F86. https:\/\/doi.org\/10.1152\/ajprenal.00077.2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"681_CR9","doi-asserted-by":"publisher","first-page":"F932","DOI":"10.1152\/ajprenal.00252.2009","volume":"297","author":"V Ram\u00edrez","year":"2009","unstructured":"Ram\u00edrez V, Trujillo J, Valdes R et al (2009) Adrenalectomy prevents renal ischemia-reperfusion injury. Am J Physiol Renal Physiol 297:F932\u2013F942. https:\/\/doi.org\/10.1152\/ajprenal.00252.2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"681_CR10","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1681\/ASN.2014121216","volume":"27","author":"J Barrera-Chimal","year":"2016","unstructured":"Barrera-Chimal J, Prince S, Fadel F et al (2016) Sulfenic acid modification of endothelin B receptor is responsible for the benefit of a nonsteroidal mineralocorticoid receptor antagonist in renal ischemia. J Am Soc Nephrol 27:398\u2013404. https:\/\/doi.org\/10.1681\/ASN.2014121216","journal-title":"J Am Soc Nephrol"},{"key":"681_CR11","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.2215\/CJN.05300516","volume":"12","author":"M Medeiros","year":"2017","unstructured":"Medeiros M, Vel\u00e1squez-Jones L, Hern\u00e1ndez AM et al (2017) Randomized controlled trial of mineralocorticoid receptor blockade in children with chronic kidney allograft nephropathy. Clin J Am Soc Nephrol 12:1291\u20131300. https:\/\/doi.org\/10.2215\/CJN.05300516","journal-title":"Clin J Am Soc Nephrol"},{"key":"681_CR12","doi-asserted-by":"publisher","first-page":"F529","DOI":"10.1152\/ajprenal.00025.2019","volume":"317","author":"LA Mortensen","year":"2019","unstructured":"Mortensen LA, Bistrup C, Stubbe J et al (2019) Effect of spironolactone for 1\u00a0yr on endothelial function and vascular inflammation biomarkers in renal transplant recipients. Am J Physiol Renal Physiol 317:F529\u2013F539. https:\/\/doi.org\/10.1152\/ajprenal.00025.2019","journal-title":"Am J Physiol Renal Physiol"},{"key":"681_CR13","unstructured":"Higgins JPT, Green S (2011) Cochrane handbook for systematic reviews of interventions. www.cochrane.org\/training\/cochrane-handbook"},{"key":"681_CR14","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J et al (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6:e1000097. https:\/\/doi.org\/10.1371\/journal.pmed.1000097","journal-title":"PLoS Med"},{"key":"681_CR15","unstructured":"Green S, Higgins P, TJ, Alderson P, Clarke M, Mulrow D C ODA (2011) Cochrane Handbook: Cochrane Reviews: Ch 8: Assessing risk of bias in included studies. 2011. In: Cochrane Handbook for: Systematic Reviews of Interventions. pp 3\u201310"},{"key":"681_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmj.315.7109.629","volume":"14","author":"M Egger","year":"2015","unstructured":"Egger M, Smith GD, Schneider M, Minder C (2015) Bias in meta\u2013analysis detected by a simple, graphical test. BMJ 14:1\u201316. https:\/\/doi.org\/10.1136\/bmj.315.7109.629","journal-title":"BMJ"},{"key":"681_CR17","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1002\/sim.1461","volume":"22","author":"N Terrin","year":"2003","unstructured":"Terrin N, Schmid CH, Lau J, Olkin I (2003) Adjusting for publication bias in the presence of heterogeneity. Statist Med 22:2113\u20132126. https:\/\/doi.org\/10.1002\/sim.1461","journal-title":"Statist Med"},{"key":"681_CR18","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00606.2018","author":"LE Morales-Buenrostro","year":"2019","unstructured":"Morales-Buenrostro LE, Ortega Trejo JA, P\u00e9rez-Villalva R et al (2019) Spironolactone reduces oxidative stress in living donor kidney transplantation: a randomized controlled trial. Am J Physiol Renal Physiol. https:\/\/doi.org\/10.1152\/ajprenal.00606.2018","journal-title":"Am J Physiol Renal Physiol"},{"key":"681_CR19","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1159\/000350539","volume":"37","author":"M Ojeda-Cervantes","year":"2013","unstructured":"Ojeda-Cervantes M, Barrera-Chimal J, Alber\u00fa J et al (2013) Mineralocorticoid receptor blockade reduced oxidative stress in renal transplant recipients: a double-blind, randomized pilot study. Am J Nephrol 37:481\u2013490. https:\/\/doi.org\/10.1159\/000350539","journal-title":"Am J Nephrol"},{"key":"681_CR20","doi-asserted-by":"publisher","first-page":"4210","DOI":"10.1172\/JCI45161","volume":"121","author":"JV Bonventre","year":"2011","unstructured":"Bonventre JV, Yang L (2011) Cellular pathophysiology of ischemic acute kidney injury. J Clin Investig 121:4210\u20134221. https:\/\/doi.org\/10.1172\/JCI45161","journal-title":"J Clin Investig"},{"key":"681_CR21","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1093\/ckj\/sfv069","volume":"8","author":"SM Sancho-Mart\u00ednez","year":"2015","unstructured":"Sancho-Mart\u00ednez SM, L\u00f3pez-Novoa JM, L\u00f3pez-Hern\u00e1ndez FJ (2015) Pathophysiological role of different tubular epithelial cell death modes in acute kidney injury. Clin Kidney J 8:548\u2013559. https:\/\/doi.org\/10.1093\/ckj\/sfv069","journal-title":"Clin Kidney J"},{"key":"681_CR22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/MNH.0000000000000190","volume":"25","author":"SG Kasimsetty","year":"2016","unstructured":"Kasimsetty SG, McKay DB (2016) Ischemia as a factor affecting innate immune responses in kidney transplantation. Curr Opin Nephrol Hypertens 25:3\u201311. https:\/\/doi.org\/10.1097\/MNH.0000000000000190","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"681_CR23","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1681\/ASN.2010040430","volume":"22","author":"DL Rosin","year":"2011","unstructured":"Rosin DL, Okusa MD (2011) Dangers within: DAMP responses to damage and cell death in kidney disease. J Am Soc Nephrol 22:416\u2013425. https:\/\/doi.org\/10.1681\/ASN.2010040430","journal-title":"J Am Soc Nephrol"},{"key":"681_CR24","doi-asserted-by":"publisher","first-page":"3160","DOI":"10.1093\/ndt\/gfs014","volume":"27","author":"K Sanchez-Pozos","year":"2012","unstructured":"Sanchez-Pozos K, Barrera-Chimal J, Garzon-Muvdi J et al (2012) Recovery from ischemic acute kidney injury by spironolactone administration. Nephrol Dial Transplant 27:3160\u20133169. https:\/\/doi.org\/10.1093\/ndt\/gfs014","journal-title":"Nephrol Dial Transplant"},{"key":"681_CR25","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1161\/01.HYP.0000255636.11931.a2","volume":"49","author":"S Shibata","year":"2007","unstructured":"Shibata S, Nagase M, Yoshida S et al (2007) Podocyte as the target for aldosterone. Hypertension 49:355\u2013364. https:\/\/doi.org\/10.1161\/01.HYP.0000255636.11931.a2","journal-title":"Hypertension"},{"key":"681_CR26","first-page":"329","volume":"10","author":"A Taye","year":"2011","unstructured":"Taye A, Morawietz H (2011) Spironolactone inhibits NADPH oxidase-induced oxidative stress and enhances eNOS in human endothelial cells. Iran J Pharm Res 10:329\u2013337","journal-title":"Iran J Pharm Res"},{"key":"681_CR27","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/nm1545","volume":"13","author":"JA Leopold","year":"2007","unstructured":"Leopold JA, Dam A, Maron BA et al (2007) Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity. Nat Med 13:189\u2013197. https:\/\/doi.org\/10.1038\/nm1545","journal-title":"Nat Med"},{"key":"681_CR28","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1016\/j.transproceed.2010.08.024","volume":"42","author":"E Gonz\u00e1lez Monte","year":"2010","unstructured":"Gonz\u00e1lez Monte E, Andr\u00e9s A, Polanco N et al (2010) Addition of spironolactone to dual blockade of renin angiotensin system dramatically reduces severe proteinuria in renal transplant patients: an uncontrolled pilot study at 6 months. Transpl Proc 42:2899\u20132901. https:\/\/doi.org\/10.1016\/j.transproceed.2010.08.024","journal-title":"Transpl Proc"},{"key":"681_CR29","doi-asserted-by":"publisher","first-page":"e0153635","DOI":"10.1371\/journal.pone.0153635","volume":"11","author":"J-P Bertocchio","year":"2016","unstructured":"Bertocchio J-P, Barbe C, Lavaud S et al (2016) Safety of eplerenone for kidney-transplant recipients with impaired renal function and receiving cyclosporine A. PLoS One 11:e0153635. https:\/\/doi.org\/10.1371\/journal.pone.0153635","journal-title":"PLoS One"},{"key":"681_CR30","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1161\/HYPERTENSIONAHA.115.04889","volume":"66","author":"B Pitt","year":"2015","unstructured":"Pitt B, Bakris GL (2015) New potassium binders for the treatment of hyperkalemia. Hypertension 66:731\u2013738. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.115.04889","journal-title":"Hypertension"},{"key":"681_CR31","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/ejhf.444","volume":"18","author":"P Bramlage","year":"2016","unstructured":"Bramlage P, Swift SL, Thoenes M et al (2016) Non-steroidal mineralocorticoid receptor antagonism for the treatment of cardiovascular and renal disease. Eur J Heart Fail 18:28\u201337. https:\/\/doi.org\/10.1002\/ejhf.444","journal-title":"Eur J Heart Fail"},{"key":"681_CR32","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000345243","volume":"50","author":"M Briet","year":"2013","unstructured":"Briet M, Schiffrin EL (2013) Vascular Actions of Aldosterone. J Vasc Res 50:89\u201399. https:\/\/doi.org\/10.1159\/000345243","journal-title":"J Vasc Res"},{"key":"681_CR33","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1056\/NEJMoa030207","volume":"348","author":"B Pitt","year":"2003","unstructured":"Pitt B, Remme W, Zannad F et al (2003) Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 348:1309\u20131321. https:\/\/doi.org\/10.1056\/NEJMoa030207","journal-title":"N Engl J Med"},{"key":"681_CR34","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/emmm.201000105","volume":"3","author":"J Barrera-Chimal","year":"2011","unstructured":"Barrera-Chimal J, P\u00e9rez-Villalva R, Cort\u00e9s-Gonz\u00e1lez C et al (2011) Hsp72 is an early and sensitive biomarker to detect acute kidney injury. EMBO Mol Med 3:5\u201320. https:\/\/doi.org\/10.1002\/emmm.201000105","journal-title":"EMBO Mol Med"},{"key":"681_CR35","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1093\/ndt\/gfy246","volume":"34","author":"J Barrera-Chimal","year":"2019","unstructured":"Barrera-Chimal J, Rocha L, Amador-Mart\u00ednez I et al (2019) Delayed spironolactone administration prevents the transition from acute kidney injury to chronic kidney disease through improving renal inflammation. Nephrol Dial Transplant 34:794\u2013801. https:\/\/doi.org\/10.1093\/ndt\/gfy246","journal-title":"Nephrol Dial Transplant"},{"key":"681_CR36","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/0272-6386(95)90119-1","volume":"25","author":"SR Silbiger","year":"1995","unstructured":"Silbiger SR, Neugarten J (1995) The impact of gender on the progression of chronic renal disease. Am J Kidney Dis 25:515\u2013533. https:\/\/doi.org\/10.1016\/0272-6386(95)90119-1","journal-title":"Am J Kidney Dis"},{"key":"681_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cccn.2003.09.010","volume":"339","author":"LL Wu","year":"2004","unstructured":"Wu LL, Chiou C-C, Chang P-Y, Wu JT (2004) Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin Chim Acta 339:1\u20139. https:\/\/doi.org\/10.1016\/j.cccn.2003.09.010","journal-title":"Clin Chim Acta"},{"key":"681_CR38","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1172\/JCI61427","volume":"122","author":"M Zhao","year":"2012","unstructured":"Zhao M, C\u00e9l\u00e9rier I, Bousquet E et al (2012) Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy. J Clin Investig 122:2672\u20132679. https:\/\/doi.org\/10.1172\/JCI61427","journal-title":"J Clin Investig"},{"key":"681_CR39","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1161\/01.RES.0000080521.15238.E5","volume":"93","author":"W Qin","year":"2003","unstructured":"Qin W, Rudolph AE, Bond BR et al (2003) Transgenic model of aldosterone-driven cardiac hypertrophy and heart failure. Circ Res 93:69\u201376. https:\/\/doi.org\/10.1161\/01.RES.0000080521.15238.E5","journal-title":"Circ Res"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-019-00681-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40620-019-00681-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-019-00681-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:56:41Z","timestamp":1777564601000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/33\/3\/529\/8328519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,11]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["681"],"URL":"https:\/\/doi.org\/10.1007\/s40620-019-00681-4","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,11]]},"assertion":[{"value":"8 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors reported that they had no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}